These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25662536)

  • 1. Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.
    Talley PJ; Chantry AD; Buckle CH
    Br Med Bull; 2015 Mar; 113(1):15-30. PubMed ID: 25662536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnosis and Treatment of Multiple Myeloma.
    Gerecke C; Fuhrmann S; Strifler S; Schmidt-Hieber M; Einsele H; Knop S
    Dtsch Arztebl Int; 2016 Jul; 113(27-28):470-6. PubMed ID: 27476706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma.
    Anderson KC
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):xi-xii. PubMed ID: 25212892
    [No Abstract]   [Full Text] [Related]  

  • 4. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma.
    Moreau P; Giralt SA
    Leuk Res; 2012 Nov; 36 Suppl 1():S13-8. PubMed ID: 23176719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches in the treatment of multiple myeloma.
    Abedi M; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):231-5. PubMed ID: 14582216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the management of multiple myeloma.
    Kumar L; Verma R; Radhakrishnan VR
    Natl Med J India; 2010; 23(4):210-8. PubMed ID: 21192514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: epidemiology and therapeutic options.
    Tuscano JM
    Manag Care; 2008 Jul; 17(7 Suppl 6):9-15. PubMed ID: 19093334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma and the newly diagnosed patient: a focus on treatment and management.
    Rajkumar SV; Kyle RA; Gertz MA
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):5-10. PubMed ID: 12520478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
    Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R
    Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents to improve outcome of allogeneic transplantation for patients with multiple myeloma.
    Kortüm M; Knop S; Einsele H
    Future Oncol; 2011 Jan; 7(1):135-43. PubMed ID: 21174544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.
    Alexanian R; Weber D; Giralt S; Dimopoulos M; Delasalle K; Smith T; Champlin R
    Bone Marrow Transplant; 2001 May; 27(10):1037-43. PubMed ID: 11438818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of allogeneic stem cell transplantation in multiple myeloma.
    Thomson KJ; Peggs KS
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):455-64. PubMed ID: 16001953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.
    Siegel DS; Vij R; Jakubowiak AJ
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):1-15. PubMed ID: 21928467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach.
    Horvath N; Hahn U; Joshua D; Dyson P; Gibson J; Stevens J; Rawling T; Barrow L; Brown R; Stephens S; Gower G; Norman J; Mills B; To LB
    Intern Med J; 2004 Apr; 34(4):167-75. PubMed ID: 15086696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of multiple myeloma.
    Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
    Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward personalized treatment in multiple myeloma based on molecular characteristics.
    Pawlyn C; Davies FE
    Blood; 2019 Feb; 133(7):660-675. PubMed ID: 30587529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.